The Valley Desk

ArticleAdvances in therapyPublished

Effectiveness and Safety of Apixaban vs Warfarin in Patients with Venous Thromboembolism with Risk Factors for Bleeding or for Recurrences

Read the publication ↗ Open access copy ↗

Regional connection

Verified An author affiliation on the Europe PMC record names Bristol Myers Squibb. Affiliation source

Publication record

Type
Article
Venue
Advances in therapy
Published
Subject terms
Humans; Hemorrhage; Pyrazoles; Pyridones; Warfarin; Anticoagulants; Risk Factors; Adult; Venous Thromboembolism; Vte; Apixaban; Major Bleeding
PubMed ID
36811795
PubMed Central ID
PMC10070226
Open access
Yes, open
Added to directory
Source checked

Report a correction or request removal